Valery Vilchez, MD
Colon & Rectal Surgery · Orange, CANPI 1073992624
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (50.1%), travel and lodging and education — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Applied Medical Resources Corporation at 51.3% of the total. Reporting peaked in 2022 at $11,724 and has fallen 69.9% since, to $3,524 in 2025.
Across 48 payments — averaging $381.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Applied Medical Resources Corporation$9K
- Intuitive Surgical$7K
- THD America, Inc.$685
- Myriad Genetic Laboratories, Inc.$179
- AbbVie$149
- Innovation Technologies Inc$135
- plus $318 from 6 others
What the payments were for
- Consulting fees$9,18850%
- Travel & lodging$3,97822%
- Food & beverage$1,6049%
- Education$3,54119%
- Gifts$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Applied Medical Resources Corporation | 15 | $9,391 |
| Intuitive Surgical | 22 | $7,466 |
| THD America, Inc. | 2 | $685 |
| Myriad Genetic Laboratories, Inc. | 1 | $179 |
| AbbVie | 1 | $149 |
| Innovation Technologies Inc | 1 | $135 |
| Axonics, Inc. | 1 | $118 |
| Boston Scientific | 1 | $73 |
| Dilon Technologies, Inc. | 1 | $70 |
| RTI Surgical, Inc | 1 | $21 |
| Medtronic | 1 | $19 |
| Guard Medical Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$3,713
- DAVINCI XI$3,500
- GelPOINT V-Path$3,375
- EPIX Laparoscopic Grasper$750
- Voyant open fusion device$375
- myRisk$179
- STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS$149
- Irrisept$135
- Axonics$118
How this compares
$18,323 in reported general payments places this provider in the 85th percentile of 176 colon & rectal surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PlenamineParenteral Amino Acid 15% No.6 | 25 | $6,784 |
| LoperamideLoperamide Hcl | 16 | $1,426 |
| Neomycin Sulfate | 20 | $120 |
| Metronidazole | 27 | $79 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Orange
- Joseph CarmichaelOrange$99K
- Anita GregoryOrange$12K
- Skandan ShanmuganOrange$8K
- Sang LeeLos Angeles$2.4M
- Pamela LeeSan Diego$544K
- Elizabeth RaskinSacramento$126K
- Shohrat AnnaberdyevRoseville$101K
- Alessio PigazziLos Angeles$100K
- Phillip FleshnerWest Hollywood$95K
- Zuri MurrellBeverly Hills$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.